#vleadersChina 2017: Meet Kai of Oviva
09.06.2017
Leaving to China on June 25 until July 4, this year’s venture leaders China forming the ‘Swiss National Startup Team China 2017’ reflect the impressive quality of Swiss startups, whose innovations come from the best universities and research institutes of Switzerland. Learn more about their growth objectives prior to the trip in our short interview series, running from May 30 to June 9 on venturelab.ch, Facebook, Twitter and LinkedIn.
 Kai Eberhardt
|
 |
You can see the whole campaign on twitter.com/venturelab_ch searching the hashtag #vleadersChina.
Oviva is a leading provider of technology-enabled medical nutritional therapy by applying technology to improve patient experience, care efficiency and effectiveness.
Why do you choose China as your business development destination?
The main factor is the need for solutions like ours. Diet-related diseases are rapidly becoming more prevalent with greater wealth in China.
What are your expectations and how will you utilize the opportunity to participate in venture leaders China to expand your business?
I hope to meet potential business partners, customers and investors in our business.
Oviva is a leading provider of technology-enabled medical nutritional therapy by applying technology to improve patient experience, care efficiency and effectiveness.
Why do you choose China as your business development destination?
The main factor is the need for solutions like ours. Diet-related diseases are rapidly becoming more prevalent with greater wealth in China.
What are your expectations and how will you utilize the opportunity to participate in venture leaders China to expand your business?
I hope to meet potential business partners, customers and investors in our business.
What aspect(s) of China would you like to decrypt/know more about, businesswise?
I'd like to understand the business culture and what setup we need to get in place for success in China.
I'd like to understand the business culture and what setup we need to get in place for success in China.